Clinical Nuclear Medicine

Skip Navigation LinksHome > January 2014 - Volume 39 - Issue 1 > 131I Therapy Using rhTSH Stimulation and Dosimetry in Metast...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e3182a75cad
Interesting Images

131I Therapy Using rhTSH Stimulation and Dosimetry in Metastatic Malignant Struma Ovarii

Yan, Jinchun MD, PhD*; Lewis, David H. MD*; Benoit, Michelle F. MD; Eary, Janet F. MD*; Mankoff, David A. MD, PhD

Collapse Box


Abstract: A 38-year-old woman with metastatic malignant struma ovarii, including massive liver metastases and retroperitoneal lymphadenopathy, underwent ovarian resection and retroperitoneal lymph nodes excision, partial hepatectomy, and radiofrequency ablation for liver metastases. She underwent thyroidectomy and received three 131I treatments using recombinant human thyrotropin stimulation and radioiodine dosimetry. posttherapy 131I imaging, anatomic images, and thyroglobulin levels showed significant diminution in the tumor burdens and remarkable decline in thyroglobulin levels. This case provided valuable information on recombinant human thyrotropin-assisted 131I ablation in conjunction with dosimetry in an unusual presentation of iodine-avid malignant struma ovarii with bulky metastases.

© 2014 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.